Century Therapeutics Inc.

NASDAQ: IPSC · Real-Time Price · USD
0.56
0.01 (1.82%)
At close: Aug 15, 2025, 3:59 PM
0.58
3.11%
Pre-market: Aug 18, 2025, 05:23 AM EDT

Century Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-126.57M -136.67M -130.93M -95.82M
Depreciation & Amortization
13.3M 13.04M 8.44M 3.75M
Stock-Based Compensation
12.69M 14.62M 10.67M 4.66M
Other Working Capital
-7.81M 11.74M 128.73M -949K
Other Non-Cash Items
-1.15M 11.28M 1.93M 1.21M
Deferred Income Tax
870K n/a n/a n/a
Change in Working Capital
-9.28M 9.38M 123.94M -2.8M
Operating Cash Flow
-110.14M -88.35M 14.05M -89M
Capital Expenditures
-154K -13.74M -30.6M -44.97M
Cash Acquisitions
-9.61M n/a -238.22M -30.34M
Purchase of Investments
-119.55M -209.03M -254M -330.03M
Sales Maturities Of Investments
176.79M 283.9M 271.48M 76.67M
Other Investing Acitivies
-119.7M n/a 238.22M 30.34M
Investing Cash Flow
47.48M 61.13M -13.13M -298.34M
Debt Repayment
n/a -10.24M n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 36.53M
Financial Cash Flow
74.56M -9.72M 27.16M 417.77M
Net Cash Flow
11.91M -36.94M 28.08M 30.43M
Free Cash Flow
-110.29M -102.08M -16.55M -133.97M